Fineotex Chemical Ltd
Fineotex Chemical Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #22 of 71 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
The short version
Fineotex targets a top-line growth of 3 to 4 times in the next 3-4 years, potentially reaching INR 3,000 crores (Page 16). - Q4 numbers are considered a base, with confidence in continued demand growth from existing customers; oilfield specialty chemicals contribute 55-60% of revenue (Page 19-20). - CCT (US acquisition) is expected to scale revenue from approx. Fineotex expects significant top-line growth, potentially 3-5x in 3-4 years, driven by strong demand from large global customers like Shell and Exxon.
From Fineotex Chemical Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Fineotex targets a top-line growth of 3 to 4 times in the next 3-4 years, potentially reaching INR 3,000 crores (Page 16).
- Q4 numbers are considered a base, with confidence in continued demand growth from existing customers; oilfield specialty chemicals contribute 55-60% of revenue (Page 19-20).
- CCT (US acquisition) is expected to scale revenue from approx. $90-100 million (Q4 annualized) to $200 million by 2028, accelerating from prior 2030 target (Page 6, 7).
- Textiles business will continue organic growth but decrease in revenue percentage due to faster oilfield segment growth (Page 19-20).
2 more points from Fineotex Chemical Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Fineotex Chemical Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Fineotex Chemical is adding more capacities at its Midland (U.S.) facility with increased R&D team members and machinery investments to support growth.
- Post-acquisition of CrudeChem (CCT), Fineotex has already invested around $7 million in capex and extended additional funds (~$7 million) for further investments.
- The company plans to double capacity at CCT, aiming to scale business towards $200 million revenue by 2028, accelerated from earlier 2030 target.
- There are ongoing discussions and plans for expansion, including inorganic growth opportunities, especially in the U.S. and Middle East markets.
2 more points from Fineotex Chemical Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fineotex Chemical Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The Q4 of FY2025-26 is considered the baseline for future growth at CCT (CrudeChem).
- The current order book at CCT is described as "too strong" and robust, indicating healthy pending orders.
- Increasing market demand and strengthened customer trust are driving a growing order pipeline.
2 more points from Fineotex Chemical Ltd's call on order book
Create a free account to keep reading this call
Fineotex Chemical Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹314 Cr, net profit ₹44 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fineotex Chem's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate Ltd (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP Ltd (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals Ltd (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fineotex Chemical Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fineotex Chemical Ltd Q4 FY26 results?
Fineotex targets a top-line growth of 3 to 4 times in the next 3-4 years, potentially reaching INR 3,000 crores (Page 16). - Q4 numbers are considered a base, with confidence in continued demand growth from existing customers; oilfield specialty chemicals contribute 55-60% of revenue (Page 19-20). - CCT (US acquisition) is expected to scale revenue from approx. Fineotex expects significant top-line growth, potentially 3-5x in 3-4 years, driven by strong demand from large global customers like Shell and Exxon.
What is Fineotex Chemical Ltd share price analysis?
Fineotex Chemical Ltd currently shows a neutral. The stock trades at a P/E of 36.8 with a market cap of ₹4,501 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fineotex Chemical Ltd planning capital expenditure?
Fineotex Chemical is adding more capacities at its Midland (U.S.) facility with increased R&D team members and machinery investments to support growth. - Post-acquisition of CrudeChem (CCT), Fineotex has already invested around $7 million in capex and extended additional funds (~$7 million) for further investments. - The company plans to double capacity at CCT, aiming to scale business towards $200 million revenue by 2028, accelerated from earlier 2030 target. - There are ongoing discussions and plans for expansion, including inorganic growth opportunities, especially in the U.S.
Keep Fineotex Chemical Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.